MENU

FTC appeals ruling in case challenging Illumina's acquisition of GRAIL

The Federal Trade Commission on Friday filed a notice of appeal in its case challenging Illumina's $7.1 billion acquisition of cancer detection company GRAIL.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
TOP
Email a Story